劉越等主編的《心血管熱點問題與專家解析(英
文版)(精)》力邀來自美國、意大利、德國、法國、
韓國、日本和中國在內的10餘國家的50多位心血管領
域的著名專家學者針對近兩年在有影響力的國際期刊
發表的大型臨床試驗、荟萃分析以及臨床與基礎研究
進行深度、抗凝在肺動脈高壓中是否真正有效以及他
汀類藥物是否適用於心力衰竭的治療等心血管領域的
困惑等等熱點問題，從而有助於我們更好理解心血管
病學發展與緊跟其步伐，促使我們更好將其轉化於臨
床實踐而造福患者，也有助於我們在創新的道路上不
斷探索與前行。

ST-Segment Elevation Myocardial Infarction
Clinical perspective of optical coherence tomography and intravascular ultrasound in STEMI patients
Aspiration thrombectomy in 2015: a TOTAL defeat?
When clinical experiences clashes against evidence based medicine: the case of aspiration thrombectomy
in primary percutaneous coronary intervention (PCI)
Therapeutic hypothermia in ST elevation myocardial infarction (STEMI): a long way to go
Therapeutic hypothermia in ST-elevation myocardial infarction (STEMI): targeting the appropriate STEMI
Dual antiplatelet therapy duration after drug-eluting stents: how long?
Prolonged dual antiplatelet therapy in renal failure: a challenging trade-off
Time for science to catch up with clinical practice?
Absorb Bioresorbable Vascular Scaffold
Bioresorbable drug eluting scaffolds--are bioresorbable stents ready for today's clinical practice?
Bioresorbable vascular scaffolds in patients with acute myocardial infarction: a new step forward
to optimized reperfusion?
Bioresorbable vascular scaffolds--time to vanish?
Overlapping meta-analyses of bioresorbable vascular scaffolds versus everolimus-eluting stents:
bringing clarity or confusion?
Bioresorbable vascular scaffolds what does the future bring?
Bioresorbable scaffold--the holy grail of percutaneous coronary intervention: fact or myth?
Percutaneous Coronary Interventions in Chronic Total Occlusion
Predictive scores in chronic total occlusions percutaneous recanalization: only fashionable or really useful?
Scoring systems for chronic total occlusion percutaneous coronary intervention: if you fail to prepare
you are preparing to fail
Chronic total improvement in ventricular function and survival
The impact of percutaneous coronary intervention of chronic total occlusions on left ventricular
function and clinical outcomes
Chronic total occlusion: no more meta-analysis, please--a randomized clinical trial is urgently needed
Meta-analyses and randomized trials investigating percutaneous coronary intervention
of chronic total occlusions:
what is left to explore?
Coronary In-Stent Restenosis
Five factors and three characteristics of coronary in-stent restenosis
Mechanism of in-stent restenosis after second-generation drug-eluting stents (DES): is it different
from bare-metal stents and
first-generation DES?
Use of intravascular ultrasound vs. optical coherence tomography for mechanism and patterns
of in-stent restenosis among bare
metal stents and drug eluting stents
In-stent restenosis and thrombosis due to metal hypersensitivity: implications for Kounis syndrome
Contemporary drug-eluting stents and companion polymers: durable is not synonymous with harm
Treatment of coronary in-stent restenosis--evidence for universal recommendation?
Treatment for in-stent restenosis: patient-specific decision rather than universal recommendation
In-stent restenosis: local drug delivery with a stent or balloon?
Network meta-analyses on in-stent restenosis treatment: dealing with complexity to clarify
efficacy and safety
Optimal interventional strategy for the treatment of coronary in-stent restenosis
Atrial Fibrillation and Left Atrial Appendage Closure
The appropriate use of risk scores in the prediction of atrial fibrillation
A meta-analysis of left atrial appendage closure for stroke prevention in atrial fibrillation--adding to the
debate but elements remain unresolved